Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021

SELL
$64.13 - $80.18 $2.03 Million - $2.54 Million
-31,644 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$53.79 - $66.98 $782,483 - $974,358
-14,547 Reduced 31.49%
31,644 $2.07 Million
Q4 2020

Feb 04, 2021

SELL
$34.56 - $57.55 $7,499 - $12,488
-217 Reduced 0.47%
46,191 $2.57 Million
Q3 2020

Oct 23, 2020

BUY
$38.36 - $46.91 $300,282 - $367,211
7,828 Added 20.29%
46,408 $1.85 Million
Q2 2020

Aug 03, 2020

SELL
$31.78 - $51.19 $47,193 - $76,017
-1,485 Reduced 3.71%
38,580 $1.73 Million
Q1 2020

May 08, 2020

BUY
$24.49 - $43.84 $981,191 - $1.76 Million
40,065 New
40,065 $1.35 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.3B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.